Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis: A Single-center, Prospective, Cohort Study

NCT02335580 is registered in ClinicalTrials.gov with General Hospital of Shenyang Military Region as lead sponsor.

NCT NCT02335580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02335580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Portal Vein Thrombosis on the Prognosis of Liver Cirrhosis: A Single-center, Prospective, Cohort Study
Lead sponsor
General Hospital of Shenyang Military Region
Phase
Observational
Overall status
Completed
Start date
December 31, 2014
Completion date
December 31, 2022
Enrollment
475 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhage, liver cirrhosis, portal vein, varicose veins, venous thrombosis